Ebvallo and Hemgenix, new ATMPs to treat post-transplant lymphoproliferative disease and haemophilia B
Recently, the EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions recommending the grating of a market authorization of two different Advanced Therapy Medicinal Products (ATMPs).…
